lgg101

Leonard Gomella, MD

Contact Dr. Gomella

1025 Walnut Street
Suite 1112
Philadelphia, PA 19107

(215) 955-6961
(215) 923-1884 fax

Most Recent Peer-reviewed Publications

  1. Intravesical rAd–IFNa/Syn3 for patients with high-grade, bacillus calmette-guerin–refractory or relapsed non–muscle-invasive bladder cancer: A phase II randomized study
  2. VAPC-1 Targeted64Cu-TP3805 kit preparation and its evaluation
  3. Prostate MRI: Value in surgical planning?
  4. Nonpalpable intratesticular mass in a young man with a history of contralateral retractile testis
  5. The urology guide to coffee and tea
  6. Development of a voided urine assay for detecting prostate cancer non-invasively: a pilot study
  7. Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts
  8. The Role of Therapeutic Layering in Optimizing Treatment for Patients With Castration-resistant Prostate Cancer (Prostate Cancer Radiographic Assessments for Detection of Advanced Recurrence II)
  9. The liquid biopsy for prostate cancer 25 years later
  10. Editorial Comment
  11. Where have all the sperm gone?
  12. Prostate cancer statistics: Anything you want them to be
  13. The perlecan-interacting growth factor progranulin regulates ubiquitination, sorting, and lysosomal degradation of sortilin
  14. Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: The largest single-institution experience to date
  15. Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies
  16. Decipher correlation patterns post prostatectomy: Initial experience from 2 342 prospective patients
  17. Clinical Influences in the Multidisciplinary Management of Small Renal Masses at a Tertiary Referral Center
  18. Potential Impact on Clinical Decision Making via a Genome-Wide Expression Profiling: A Case Report
  19. An Approach Using PSA Levels of 1.5 ng/mL as the Cutoff for Prostate Cancer Screening in Primary Care
  20. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer